Has your dose gone up without new labs?
That is the first sign worth a review. The AUA guideline advises adjusting the dose to bring total testosterone into the middle third of the normal range, about 450 to 600 ng/dL, and measuring it every 6 to 12 months once treatment is underway. A dose change should rest on a result, not on a feeling alone.
Look at your own history. Was each increase preceded by a blood test? Was that test timed the same way each time, for example just before a scheduled injection? If you cannot answer those questions from your records, a review will start by filling the gap. Our page on your target testosterone level on TRT explains how the target is set, and our answer on signs your TRT dose is too high covers what overshooting feels like.
Is anyone checking your PSA and blood count?
Both should appear in your records at regular points. The AUA recommends checking hematocrit every 6 to 12 months, or sooner depending on prior values, to keep it below 54%. The testosterone cypionate label likewise says hemoglobin and hematocrit should be checked periodically during long-term use.
For the prostate, the Endocrine Society recommends reassessing risk 3 to 12 months after starting, and urological referral for a confirmed PSA rise of more than 1.4 ng/mL in the first year. After that, monitoring follows standard prostate screening guidance. If your file holds no blood count or PSA since you started, that alone justifies a second look. Our pages on a rising PSA on TRT and high hematocrit on TRT explain what each result means.
Was an estrogen blocker added without a test?
An aromatase inhibitor added on a schedule, rather than in response to a result, is a good reason to ask for a review. The AUA recommends measuring estradiol in men who develop breast symptoms or gynecomastia on testosterone, and in all men taking an aromatase inhibitor.
Estradiol does tend to rise on testosterone; the AUA notes this is not uncommon. A rise on its own is not automatically a problem, which is why the decision should rest on symptoms and a measured level. Our pages on anastrozole on TRT and the sensitive estradiol test explain both sides.
Are side effects being brushed aside?
Some side effects are minor, but several deserve a prompt answer. MedlinePlus lists these among the ones to report right away:
- Swelling of the hands, feet, ankles or lower legs
- Difficulty breathing, especially during sleep
- Enlarged or painful breasts
- Trouble urinating or a weak stream
- Erections that happen too often or last too long
- Mood changes, including depression or anxiety
If you have raised one of these more than once without a plan to address it, a fresh set of eyes is reasonable. So is a review if you feel no better after several months: the AUA advises discussing stopping three to six months after starting when levels have normalized but symptoms have not improved.
Related question: does a review mean switching clinics?
No. A second opinion can confirm your plan, suggest a specific change you take back to your current clinician, or lead you to move your care. Only the last involves transferring, and our page on transferring TRT care covers that if you choose it. If you are not on TRT yet and were turned down, our answer on a second opinion after a doctor said no fits your situation better.
Getting your TRT reviewed at Ultimate Male
Bring your records to a free 10-minute call, then come in for a draw timed just before your next scheduled dose at San Gabriel or Downey. Results return in 24 to 48 hours, and a PA-C or MD walks through your history with you: the original diagnosis, each dose change, your blood count, PSA and estradiol trends, and any side effects still on your list.
You will hear what looks sound, what is missing and what, if anything, should change. Keep taking your current dose as directed in the meantime. When you are ready, book a review and bring the full picture of your testosterone therapy so far.
